qIHC involves the use of antibodies that specifically bind to the protein of interest. These antibodies are usually conjugated with a detectable marker such as an enzyme, fluorescent dye, or radioactive element. After binding to the target protein, the signal from the marker is quantified using various imaging techniques and software. This quantification can be done using digital pathology tools that analyze the intensity and distribution of the signal within the tissue.
